标题
Marketing approval of mogamulizumab
作者
关键词
-
出版物
mAbs
Volume 4, Issue 4, Pages 419-425
出版商
Informa UK Limited
发表日期
2012-06-29
DOI
10.4161/mabs.20996
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EB66 cell line, a duck embryonic stem cell-derived substrate for the industrial production of therapeutic monoclonal antibodies with enhanced ADCC activity
- (2014) Stéphane Olivier et al. mAbs
- Biosimilar, Biobetter, and Next Generation Antibody Characterization by Mass Spectrometry
- (2012) Alain Beck et al. ANALYTICAL CHEMISTRY
- Isotype and glycoform selection for antibody therapeutics
- (2012) Roy Jefferis ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies
- (2012) L. H. Sehn et al. BLOOD
- An innovative approach for the characterization of the isoforms of a monoclonal antibody product
- (2012) Shanmuuga Sundaram et al. mAbs
- 7th Annual European Antibody Congress 2011
- (2012) Alexey A. Lugovskoy et al. mAbs
- Galactosylation variations in marketed therapeutic antibodies
- (2012) T. Shantha Raju et al. mAbs
- Lepidopteran cells, an alternative for the production of recombinant antibodies?
- (2012) Martine Cérutti et al. mAbs
- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab
- (2012) John R. Gasdaska et al. MOLECULAR IMMUNOLOGY
- GMP issues for recombinant plant-derived pharmaceutical proteins
- (2011) Rainer Fischer et al. BIOTECHNOLOGY ADVANCES
- Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose
- (2011) Michael J. Gramer et al. BIOTECHNOLOGY AND BIOENGINEERING
- Effects of cell culture conditions on antibody N-linked glycosylation-what affects high mannose 5 glycoform
- (2011) Efren Pacis et al. BIOTECHNOLOGY AND BIOENGINEERING
- High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans
- (2011) A. M. Goetze et al. GLYCOBIOLOGY
- Phase I Pharmacokinetic and Pharmacodynamic Dose-Escalation Study of RG7160 (GA201), the First Glycoengineered Monoclonal Antibody Against the Epidermal Growth Factor Receptor, in Patients With Advanced Solid Tumors
- (2011) Luis G. Paz-Ares et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 1 study of anti-epidermal growth factor receptor monoclonal antibody in patients with solid tumors
- (2011) Chong Wang et al. mAbs
- 2nd Charles Richet et Jules Héricourt Workshop
- (2011) Arnaud Daguet et al. mAbs
- Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis
- (2011) Delphine Mariotte et al. mAbs
- Glycoengineered Pichia produced anti-HER2 is comparable to trastuzumab in preclinical study
- (2011) Ningyan Zhang et al. mAbs
- Anti-galactose-α-1,3-galactose IgE from allergic patients does not bind α-galactosylated glycans on intact therapeutic antibody Fc domains
- (2011) Jeroen J Lammerts van Bueren et al. NATURE BIOTECHNOLOGY
- Glycoprotein production in moss bioreactors
- (2011) Eva L. Decker et al. PLANT CELL REPORTS
- Production of therapeutic antibodies with controlled fucosylation
- (2010) Naoko Yamane-Ohnuki et al. mAbs
- Evolution of anti- CD20 monoclonal antibody therapeutics in oncology
- (2010) Ezogelin Oflazoglu et al. mAbs
- Assessing monoclonal antibody product quality attribute criticality through clinical studies
- (2010) Andrew M. Goetze et al. mAbs
- Engineered therapeutic antibodies with improved effector functions
- (2009) Tsuguo Kubota et al. CANCER SCIENCE
- GlycoFi's technology to control the glycosylation of recombinant therapeutic proteins
- (2009) Alain Beck et al. Expert Opinion on Drug Discovery
- Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins
- (2008) Alain Beck et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started